RAPIGEN Trademark

Trademark Overview

On Tuesday, March 22, 2022, a trademark application was filed for RAPIGEN with the United States Patent and Trademark Office. The USPTO has given the RAPIGEN trademark a serial number of 97323787. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, August 13, 2024. This trademark is owned by Rapigen Inc.. The RAPIGEN trademark is filed in the Medical Instrument Products category with the following description:

Medical diagnostic test kits for COVID-19 testing; diagnostic testing kits comprised of medical diagnostic reagents and assays that test for the presence of COVID-19; medical diagnostic kits and equipments; medical diagnostics; in-vitro diagnostics; medical software for diagnostic testing
rapigen

General Information

Serial Number97323787
Word MarkRAPIGEN
Filing DateTuesday, March 22, 2022
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, August 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical diagnostic test kits for COVID-19 testing; diagnostic testing kits comprised of medical diagnostic reagents and assays that test for the presence of COVID-19; medical diagnostic kits and equipments; medical diagnostics; in-vitro diagnostics; medical software for diagnostic testing

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, March 25, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRapigen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 16648
KR

Trademark Events

Event DateEvent Description
Friday, March 25, 2022NEW APPLICATION ENTERED
Friday, March 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 4, 2023ASSIGNED TO EXAMINER
Thursday, January 5, 2023NON-FINAL ACTION WRITTEN
Thursday, January 5, 2023NON-FINAL ACTION E-MAILED
Thursday, January 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 6, 2023SUSPENSION LETTER WRITTEN
Thursday, April 6, 2023LETTER OF SUSPENSION E-MAILED
Thursday, April 6, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, June 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 6, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, June 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 12, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 12, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 12, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, June 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 8, 2023SUSPENSION INQUIRY WRITTEN
Friday, December 8, 2023INQUIRY TO SUSPENSION E-MAILED
Friday, December 8, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, March 1, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, August 13, 2024SUSPENSION LETTER WRITTEN
Tuesday, August 13, 2024LETTER OF SUSPENSION E-MAILED
Tuesday, August 13, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Related Keywords

rapigen medical diagnostic kits testing diagnostics covid test vitro software equipments